Ameliorating effect of saporin-conjugated anti-CD11b monoclonal antibody in a murine T-cell-mediated chronic colitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 7, 2006, Pages 1136-1142

  Kanai, Takanori ^a,c   Uraushihara, Koji ^a   Totsuka, Teruji ^a   Nemoto, Yasuhiro ^a   Fujii, Rei ^a   Kawamura, Takahiro ^a   Makita, Shin ^a   Sawada, Daisuke ^a   Yagita, Hideo ^b   Okumura, Ko ^b   Watanabe, Mamoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Crohn's disease; Macrophages; Murine model; Targeting; Therapy

Indexed keywords

CD11B ANTIBODY; CD11B ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; GAMMA INTERFERON; MONOCLONAL ANTIBODY; SAPORIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COLITIS; COLON; CONJUGATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; LAMINA PROPRIA; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

EID: 33745202616     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04391.x     Document Type: Article

References (24)

1. Bouma G Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 2003 3 : 521 33.
2. Podolsky DK. Inflammatory bowel disease. N. Engl. J. Med. 2002 347 : 417 29.
3. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998 115 : 182 205.
4. Stagg AJ Hart AL Knight SC Kamm MA. The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut 2003 52 : 1522 9.
5. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 2003 3 : 331 41.
6. Stumbles PA McWilliam AS Holt PG. Dendritic cells and mucosal macrophages. In : Ogra PL Mestecky J Lamm ME Strober W Bienenstock J McGhee JR, eds. Mucosal Immunology, 2nd edn. San Diego : Academic Press, 1999 397 412.
7. Mahida YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm. Bowel Dis. 2000 6 : 21 33.
8. Sandborn WJ Targan SR. Biological therapy of inflammatory bowel disease. Gastroenterology 2002 122 : 1592 608.
9. Kanai T Watanabe M Okazawa A et al. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. Gastroenterology 2001 121 : 875 88.
10. + T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol. 1993 5 : 1461 71.
11. high T cell-transferred SCID mice by anti-OX40L mAb administration. Am. J. Physiol. GI Liver 2003 284 : G595 603.
12. Totsuka T Kanai T Iiyama R et al. Ameliorating effect of anti-ICOS monoclonal antibody in a murine model of chronic colitis. Gastroenterology 2003 124 : 410 21.
13. + regulatory T cells. J. Immunol. 2003 171 : 708 16.
14. Kanai T Totsuka T Uraushihara K et al. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 2003 171 : 4156 63.
15. Okazawa A Kanai T Watanabe M et al. Synergistic activation of human lamina propria lymphocytes by the combined stimulation with IL-12 and IL-18 independently from TCR engagement. Am. J. Gastroenterol. 2002 97 : 3108 17.
16. Yamamoto M Yoshizaki K Kishimoto T Ito H. IL-6 is required for the development of Th1 cell-mediated murine colitis. J. Immunol. 2000 164 : 4878 82.
17. Strober W Fuss IJ Blumberg RS. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 2002 20 : 495 549.
18. Kanai T Uraushihara K Okazawa A Hibi T Watanabe M. Macrophage-derived IL-18 targeting for the treatment of Crohn's disease. Curr. Drug Targets Inflamm. Allergy 2003 2 : 131 6.
19. Dieleman LA Ridwan BU Tennyson GS et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994 107 : 1643 52.
20. Takeda K Clausen BE Kaisho T et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999 10 : 39 49.
21. hi T cells. J. Exp. Med. 1999 190 : 1479 92.
22. van Dullemen HM van Deventer SJ Hommes DW et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995 109 : 129 35.
23. Targan SR Hanauer SB van Deventer SJ et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N. Engl. J. Med. 1997 337 : 1029 35.
24. Lugering A Schmidt M Lugering N et al. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology 2001 121 : 1145 57.